Basis: Latest stored market observation. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 16.64x is in line with its 5-year average of 16.46x, around the middle of its 5-year range (11.12x–25.80x).
As of Tuesday, September 8, 2026. 16.31% above its 12-month average of 14.31x.
EV/EBITDA RATIO
16.64x
EV/EBITDA RATIO AVG TTM
14.31x
EV/EBITDA RATIO AVG 3Y
15.32x
EV/EBITDA RATIO AVG 5Y
16.46x
EV/EBITDA RATIO AVG 10Y
18.87x
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.31%
CURRENT VS 3Y AVG
+8.59%
CURRENT VS 5Y AVG
+1.10%
CURRENT VS 10Y AVG
-11.82%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
16.32x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+1.93%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$42.01B
EV/EBITDA Ratio
16.64x
TTM Avg
14.31x
3Y Avg
15.32x
5Y Avg
16.46x
Market Cap
$42.85B
EV/EBITDA Ratio
19.06x
TTM Avg
17.33x
3Y Avg
200.33x
5Y Avg
160.95x
Market Cap
$41.10B
EV/EBITDA Ratio
26.58x
TTM Avg
34.11x
3Y Avg
33.79x
5Y Avg
36.80x
Market Cap
$40.90B
EV/EBITDA Ratio
22.91x
TTM Avg
22.30x
3Y Avg
23.04x
5Y Avg
23.40x
Market Cap
$49.65B
EV/EBITDA Ratio
11.87x
TTM Avg
12.51x
3Y Avg
14.26x
5Y Avg
14.91x
Market Cap
$49.79B
EV/EBITDA Ratio
24.00x
TTM Avg
26.11x
3Y Avg
27.00x
5Y Avg
29.41x
Market Cap
$34.27B
EV/EBITDA Ratio
33.69x
TTM Avg
94.60x
3Y Avg
123.84x
5Y Avg
123.84x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $42.01B | 16.64x | 14.31x | 15.32x | 16.46x |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.85B | 19.06x | 17.33x | 200.33x | 160.95x |
| IDEXX Laboratories, Inc. (IDXX)vs › | $41.10B | 26.58x | 34.11x | 33.79x | 36.80x |
| Agilent Technologies, Inc. (A)vs › | $40.90B | 22.91x | 22.30x | 23.04x | 23.40x |
| Humana Inc. (HUM)vs › | $47.95B | 20.23x | 17.02x | 14.41x | 14.58x |
| Becton, Dickinson and Company (BDX)vs › | $49.65B | 11.87x | 12.51x | 14.26x | 14.91x |
| Edwards Lifesciences Corporation (EW)vs › | $49.79B | 24.00x | 26.11x | 27.00x | 29.41x |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $34.27B | 33.69x | 94.60x | 123.84x | 123.84x |
| Alcon Inc. (ALC)vs › | $33.61B | 17.18x | 15.65x | 18.31x | 19.52x |
| DexCom, Inc. (DXCM)vs › | $31.88B | 23.81x | 25.46x | 43.36x | 69.55x |
At 16.6, EV/EBITDA is near its 13-year median — higher than 45% of readings in its 13-year history.
13-year low
10.9
median
17.2
13-year high
28.4
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-09-08 | 16.64x |
| 2026-09-04 | 17.05x |
| 2026-09-03 | 17.24x |
| 2026-09-02 | 16.86x |
| 2026-09-01 | 16.60x |
| 2026-08-31 | 16.73x |
| 2026-08-28 | 16.76x |
| 2026-08-27 | 16.79x |
| 2026-08-26 | 16.75x |
| 2026-08-25 | 16.65x |
| 2026-08-24 | 16.69x |
| 2026-08-21 | 16.67x |
| 2026-08-20 | 16.49x |
| 2026-08-19 | 16.16x |
| 2026-08-18 | 15.71x |
| 2026-08-17 | 15.77x |
| 2026-08-14 | 15.55x |
| 2026-08-13 | 15.78x |
| 2026-08-12 | 15.79x |
| 2026-08-11 | 15.90x |
| 2026-08-10 | 15.81x |
| 2026-08-07 | 15.65x |
| 2026-08-06 | 15.34x |
| 2026-08-05 | 15.52x |
| 2026-08-04 | 15.14x |
| 2026-08-03 | 15.39x |
| 2026-07-31 | 15.47x |
| 2026-07-30 | 15.60x |
| 2026-07-29 | 16.08x |
| 2026-07-28 | 15.85x |
| 2026-07-27 | 14.49x |
| 2026-07-24 | 14.24x |
| 2026-07-23 | 14.21x |
| 2026-07-22 | 13.77x |
| 2026-07-21 | 13.93x |
| 2026-07-20 | 14.04x |
| 2026-07-17 | 14.15x |
| 2026-07-16 | 14.36x |
| 2026-07-15 | 14.18x |
| 2026-07-14 | 14.23x |
| 2026-07-13 | 14.22x |
| 2026-07-10 | 14.23x |
| 2026-07-09 | 14.29x |
| 2026-07-08 | 14.03x |
| 2026-07-07 | 14.25x |
| 2026-07-06 | 14.14x |
| 2026-07-02 | 14.19x |
| 2026-07-01 | 14.00x |
| 2026-06-30 | 13.52x |
| 2026-06-29 | 13.52x |
| 2026-06-26 | 13.41x |
| 2026-06-25 | 13.18x |
| 2026-06-24 | 13.14x |
| 2026-06-23 | 12.44x |
| 2026-06-22 | 12.27x |
| 2026-06-18 | 12.27x |
| 2026-06-17 | 12.41x |
| 2026-06-16 | 12.83x |
| 2026-06-15 | 12.79x |
| 2026-06-12 | 12.94x |
| 2026-06-11 | 12.92x |
| 2026-06-10 | 12.98x |
| 2026-06-09 | 13.17x |
| 2026-06-08 | 13.05x |
| 2026-06-05 | 13.04x |
| 2026-06-04 | 13.21x |
| 2026-06-03 | 12.97x |
| 2026-06-02 | 12.90x |
| 2026-06-01 | 13.20x |
| 2026-05-29 | 12.98x |
| 2026-05-28 | 12.92x |
| 2026-05-27 | 12.17x |
| 2026-05-26 | 11.99x |
| 2026-05-22 | 12.28x |
| 2026-05-21 | 12.28x |
| 2026-05-20 | 12.45x |
| 2026-05-19 | 12.54x |
| 2026-05-18 | 12.52x |
| 2026-05-15 | 12.34x |
| 2026-05-14 | 12.41x |
| 2026-05-13 | 12.50x |
| 2026-05-12 | 12.63x |
| 2026-05-11 | 12.55x |
| 2026-05-08 | 12.81x |
| 2026-05-07 | 12.80x |
| 2026-05-06 | 12.70x |
| 2026-05-05 | 12.69x |
| 2026-05-04 | 12.20x |
| 2026-05-01 | 12.04x |
| 2026-04-30 | 12.07x |
| 2026-04-29 | 11.99x |
| 2026-04-28 | 12.10x |
| 2026-04-27 | 12.35x |
| 2026-04-24 | 12.27x |
| 2026-04-23 | 12.19x |
| 2026-04-22 | 12.92x |
| 2026-04-21 | 12.94x |
| 2026-04-20 | 12.99x |
| 2026-04-17 | 12.98x |
| 2026-04-16 | 12.75x |
| 2026-04-15 | 13.06x |
| 2026-04-14 | 12.92x |
| 2026-04-13 | 12.75x |
| 2026-04-10 | 12.52x |
| 2026-04-09 | 12.60x |
| 2026-04-08 | 12.78x |
| 2026-04-07 | 12.69x |
| 2026-04-06 | 12.69x |
| 2026-04-02 | 12.82x |
| 2026-04-01 | 12.77x |
| 2026-03-31 | 12.68x |
| 2026-03-30 | 12.46x |
| 2026-03-27 | 12.35x |
| 2026-03-26 | 12.62x |
| 2026-03-25 | 12.44x |
| 2026-03-24 | 12.46x |
| 2026-03-23 | 12.50x |
| 2026-03-20 | 12.46x |
| 2026-03-19 | 12.48x |
| 2026-03-18 | 12.51x |
| 2026-03-17 | 12.58x |
| 2026-03-16 | 12.40x |
| 2026-03-13 | 12.39x |
| 2026-03-12 | 12.30x |
| 2026-03-11 | 12.73x |
| 2026-03-10 | 12.70x |
| 2026-03-09 | 13.08x |
| 2026-03-06 | 12.88x |
| 2026-03-05 | 13.08x |
| 2026-03-04 | 13.05x |
| 2026-03-03 | 12.85x |
| 2026-03-02 | 12.87x |
| 2026-02-27 | 13.10x |
| 2026-02-26 | 12.69x |
| 2026-02-25 | 12.25x |
| 2026-02-24 | 12.40x |
| 2026-02-23 | 12.27x |
| 2026-02-20 | 12.43x |
| 2026-02-19 | 12.62x |
| 2026-02-18 | 12.71x |
| 2026-02-17 | 12.38x |
| 2026-02-13 | 12.70x |
| 2026-02-12 | 12.80x |
| 2026-02-11 | 13.23x |
| 2026-02-10 | 13.50x |
| 2026-02-09 | 14.03x |
| 2026-02-06 | 13.76x |
| 2026-02-05 | 13.42x |
| 2026-02-04 | 14.54x |
| 2026-02-03 | 14.61x |
| 2026-02-02 | 16.03x |
| 2026-01-30 | 15.97x |
| 2026-01-29 | 16.26x |
| 2026-01-28 | 16.47x |
| 2026-01-27 | 16.54x |
| 2026-01-26 | 16.46x |
| 2026-01-23 | 16.24x |
| 2026-01-22 | 16.44x |
| 2026-01-21 | 16.56x |
| 2026-01-20 | 16.16x |
| 2026-01-16 | 16.37x |
| 2026-01-15 | 16.55x |
| 2026-01-14 | 16.56x |
| 2026-01-13 | 16.57x |
| 2026-01-12 | 16.53x |
| 2026-01-09 | 16.61x |
| 2026-01-08 | 16.65x |
| 2026-01-07 | 16.71x |
| 2026-01-06 | 16.51x |
| 2026-01-05 | 16.21x |
| 2026-01-02 | 15.73x |
| 2025-12-31 | 15.73x |
| 2025-12-30 | 15.85x |
| 2025-12-29 | 15.82x |
| 2025-12-26 | 15.81x |
| 2025-12-24 | 15.76x |
| 2025-12-23 | 15.72x |
| 2025-12-22 | 15.68x |
| 2025-12-19 | 15.48x |
| 2025-12-18 | 15.58x |
| 2025-12-17 | 15.52x |
| 2025-12-16 | 15.54x |
| 2025-12-15 | 15.64x |
| 2025-12-12 | 15.57x |
| 2025-12-11 | 15.76x |
| 2025-12-10 | 15.60x |
| 2025-12-09 | 15.35x |
| 2025-12-08 | 15.63x |
| 2025-12-05 | 15.75x |
| 2025-12-04 | 15.70x |
| 2025-12-03 | 15.82x |
| 2025-12-02 | 15.74x |
| 2025-12-01 | 15.89x |
| 2025-11-28 | 15.97x |
| 2025-11-26 | 16.06x |
| 2025-11-25 | 16.07x |
| 2025-11-24 | 15.87x |
| 2025-11-21 | 15.70x |
| 2025-11-20 | 15.30x |
| 2025-11-19 | 15.32x |
| 2025-11-18 | 15.31x |
| 2025-11-17 | 15.25x |
| 2025-11-14 | 15.48x |
| 2025-11-13 | 15.63x |
| 2025-11-12 | 15.49x |
| 2025-11-11 | 15.37x |
| 2025-11-10 | 15.09x |
| 2025-11-07 | 14.95x |
| 2025-11-06 | 14.97x |
| 2025-11-05 | 14.94x |
| 2025-11-04 | 14.98x |
| 2025-11-03 | 15.13x |
| 2025-10-31 | 15.26x |
| 2025-10-30 | 15.27x |
| 2025-10-29 | 15.34x |
| 2025-10-28 | 15.35x |
| 2025-10-27 | 15.55x |
| 2025-10-24 | 15.71x |
| 2025-10-23 | 15.68x |
| 2025-10-22 | 15.57x |
| 2025-10-21 | 15.62x |
| 2025-10-20 | 15.27x |
| 2025-10-17 | 14.88x |
| 2025-10-16 | 14.94x |
| 2025-10-15 | 14.80x |
| 2025-10-14 | 14.89x |
| 2025-10-13 | 14.83x |
| 2025-10-10 | 14.54x |
| 2025-10-09 | 14.79x |
| 2025-10-08 | 14.67x |
| 2025-10-07 | 14.68x |
| 2025-10-06 | 14.90x |
| 2025-10-03 | 14.98x |
| 2025-10-02 | 14.86x |
| 2025-10-01 | 14.84x |
| 2025-09-30 | 14.11x |
| 2025-09-29 | 13.62x |
| 2025-09-26 | 13.56x |
| 2025-09-25 | 13.41x |
| 2025-09-24 | 13.65x |
| 2025-09-23 | 13.93x |
| 2025-09-22 | 14.00x |
| 2025-09-19 | 13.97x |
| 2025-09-18 | 14.12x |
| 2025-09-17 | 13.94x |
| 2025-09-16 | 13.94x |
| 2025-09-15 | 13.90x |
| 2025-09-12 | 13.97x |
| 2025-09-11 | 14.15x |
| 2025-09-10 | 13.79x |
| 2025-09-09 | 14.09x |
| 2025-09-08 | 13.99x |
| 2025-09-05 | 13.99x |
| 2025-09-04 | 13.80x |
| 2025-09-03 | 13.83x |
| 2025-09-02 | 13.78x |
| 2025-08-29 | 14.15x |
| 2025-08-28 | 14.05x |
| 2025-08-27 | 14.05x |
| 2025-08-26 | 13.99x |
Showing the most recent 260 of 3,353 data points. The chart above shows the full history.
